Showing results (411-420 of 456) with videos related to
Sort By:
Pageof 46
Frontiers in Psychiatry|April 24, 2015
Speed Matters: Relationship between Speed of Eye Movements and Modification of Aversive Autobiographical MemoriesSuzanne Chantal van Veen, Kevin van Schie, Leoniek D N V Wijngaards-de Meij, et al.Medizinische Klinik (Munich, Germany : 1983)|November 15, 1992
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group]R Fuchs, M Löffler, M Pfreundschuh, et al.Leukemia & Lymphoma|June 1, 1994
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's diseaseR Fuchs, M Löffler, M Pfreundschuh, et al.Depression and Anxiety|February 24, 2015
Updated meta-analysis of classical fear conditioning in the anxiety disordersPuck Duits, Danielle C Cath, Shmuel Lissek, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 2, 2022
A meta-analysis of conditioned fear generalization in anxiety-related disordersSamuel E Cooper, Eva A M van Dis, Muriel A Hagenaars, et al.The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonistM Clozel, V Breu, G A Gray, et al.General Hospital Psychiatry|July 9, 2002
Posttraumatic stress disorder after pre-eclampsia: an exploratory studyIris M Engelhard, Maartje van Rij, Inge Boullart, et al.Journal of Affective Disorders|January 24, 2020
Mothers' emotions after pediatric burn injury: Longitudinal associations with posttraumatic stress and depressive symptoms 18 months postburnMarthe R Egberts, Iris M Engelhard, Rens van de Schoot, et al.Current Addiction Reports|March 29, 2021
Review of Popularity and Quality Standards of Opioid-Related Smartphone AppsRoger Vilardaga, Tykira Fisher, Paige E Palenski, et al.Nature|October 21, 1993
Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonistM Clozel, V Breu, K Burri, et al.Pageof 46